Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Factors associated with viral RNA shedding and evaluation of potential viral infectivity at returning to school in influenza outpatients after treatment with baloxavir marboxil and neuraminidase inhibitors during 2013/2014–2019/2020 seasons in Japan: an observational study

Fig. 2

Comparison of influenza viral clearance by age, treatment, vaccination groups with or without PA variants. a and b; Age groups, c and d; treatment groups, e and f; influenza vaccination status, and g; emergence of PA variants. Emergence of PA variants was not analyzed for influenza B because of no detection. ad were analyzed using Kruskal–Wallis test, and Bonferroni correction was applied as a post-hoc test for each pair; eg were analyzed using Mann–Whitney test. The p-value or no significance in the upper right corner of each figure was determined using Kruskal–Wallis test or Mann–Whitney test. The p-value above the two connected groups in the figure was determined using Bonferroni correction. BA, baloxavir; LA, laninamivir; OS, oseltamivir; ZA, zanamivir; NS, not significant

Back to article page